Overview
Availability
- Dr Connor OLeary is:
- Available for supervision
Works
Search Professor Connor OLeary’s works on UQ eSpace
2025
Journal Article
Colorectal cancer in pregnancy: case discussions and real-world data as well as literature review on current knowledge
Poulgrain, Suzanne, Gibbons, Ted, O’Leary, Cian, Feng, Sophie, Jain, Vikram and O’Leary, Connor Gerard (2025). Colorectal cancer in pregnancy: case discussions and real-world data as well as literature review on current knowledge. The Oncologist, 30 (7) oyaf097, 1-8. doi: 10.1093/oncolo/oyaf097
2025
Journal Article
CTRIAL-IE (ICORG) 15-34: The impact of the 21 gene breast recurrence score® assay on chemotherapy prescribing in oestrogen receptor positive, lymph node positive early stage breast cancer in Ireland
Mullally, W. J., Hassan, A., Keegan, N., O'Leary, C., Mcsorley, L., Mahgoub, T., O'Reilly, S., Walshe, J., Kennedy, M. J., Coate, L., O'Connor, M., Keane, M., Kelly, C. M., Duffy, K., Murphy, C. G., Milewski, M., Molloy, S., Egan, K., Murphy, V., Breathnach, O. S., Grogan, L., Hennessy, B. T. and Morris, P. G. (2025). CTRIAL-IE (ICORG) 15-34: The impact of the 21 gene breast recurrence score® assay on chemotherapy prescribing in oestrogen receptor positive, lymph node positive early stage breast cancer in Ireland. Irish Journal of Medical Science, 194 (3), 839-846. doi: 10.1007/s11845-025-03922-7
2025
Journal Article
Rearranged during transfection (RET) lung cancer - update on targeted therapies
Mullally, W. J., O'Leary, C. G. and O'Byrne, K. J. (2025). Rearranged during transfection (RET) lung cancer - update on targeted therapies. Lung Cancer, 200 108083, 1-11. doi: 10.1016/j.lungcan.2025.108083
2024
Journal Article
Characterisation of circulating tumor‐associated and immune cells in patients with advanced‐stage non‐small cell lung cancer
Yaghoubi Naei, Vahid, Ivanova, Ekaterina, Mullally, William, O'Leary, Connor G, Ladwa, Rahul, O'Byrne, Ken, Warkiani, Majid E and Kulasinghe, Arutha (2024). Characterisation of circulating tumor‐associated and immune cells in patients with advanced‐stage non‐small cell lung cancer. Clinical and Translational Immunology, 13 (6) e1516, e1516. doi: 10.1002/cti2.1516
2023
Journal Article
Targeted therapies for kirsten rat sarcoma (KRAS) G12C mutant metastatic non-small-cell lung cancers
O'Leary, Cian, Murphy, Grace, Yeung, Yong, Tang, Ming, Jain, Vikram and O'Leary, Connor G. (2023). Targeted therapies for kirsten rat sarcoma (KRAS) G12C mutant metastatic non-small-cell lung cancers. Cancers, 15 (23) 5582, 5582. doi: 10.3390/cancers15235582
2023
Journal Article
Liquid biopsy snapshots of key phosphoproteomic pathways in lung cancer patients for diagnosis and therapy monitoring
Ahmed, Mostak, Wuethrich, Alain, Constantin, Nicolas, Shanmugasundaram, Karthik Balaji, Mainwaring, Paul, Kulasinghe, Arutha, O’Leary, Connor, O’Byrne, Ken, Sina, Abu Ali Ibn, Carrascosa, Laura G. and Trau, Matt (2023). Liquid biopsy snapshots of key phosphoproteomic pathways in lung cancer patients for diagnosis and therapy monitoring. Analytical Chemistry, 95 (22), 8522-8532. doi: 10.1021/acs.analchem.3c00519
2023
Conference Publication
Immune profiling of immunotherapy and adjuvant chemotherapy pretreatment NSCLC tissues by CODEX
Monkman, James, Moradi, Afshin, O'Leary, Connor, Wu, Zhenqin, Hamel, Steven, Mason, David, Schneider, Fabian, Mansfield, James Robert, Meyer, Aaron, O'Byrne, Ken and Kulasinghe, Arutha (2023). Immune profiling of immunotherapy and adjuvant chemotherapy pretreatment NSCLC tissues by CODEX. AACR Annual Meeting 2023, Orlando, FL United States, 14-19 April 2023. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.am2023-4627
2023
Conference Publication
Polo-like kinase-1 is a novel biomarker in resected non-small cell lung cancer treated with adjuvant platinum-based chemotherapy
O'Leary, Connor, Monkman, James, Richard, Derek, O'Byrne, Kenneth, Kulasinghe, Arutha and Adams, Mark (2023). Polo-like kinase-1 is a novel biomarker in resected non-small cell lung cancer treated with adjuvant platinum-based chemotherapy. Australian Lung Cancer Conference 2023, Gold Coast, QLD Australia, 15-17 February 2023. Richmond, VIC Australia: John Wiley & Sons.
2023
Other Outputs
Clinical validation of candidate biomarkers in non-small cell lung cancer
O'Leary, Connor Gerard (2023). Clinical validation of candidate biomarkers in non-small cell lung cancer. Master's Thesis, School of Biomedical Sciences, Queensland University of Technology. doi: 10.5204/thesis.eprints.238536
2022
Journal Article
Prognostic value of integrating circulating tumour cells and cell-free DNA in non-small cell lung cancer
Kapeleris, Joanna, Bark, Juliana Müller, Ranjit, Shanon, Irwin, Darryl, Hartel, Gunter, Warkiani, Majid Ebrahimi, Leo, Paul, O’Leary, Connor, Ladwa, Rahul, O'Byrne, Kenneth, Hughes, Brett G.M. and Punyadeera, Chamindie (2022). Prognostic value of integrating circulating tumour cells and cell-free DNA in non-small cell lung cancer. Heliyon, 8 (7) e09971, 1-9. doi: 10.1016/j.heliyon.2022.e09971
2022
Journal Article
Pembrolizumab-induced toxic epidermal necrolysis: case report
Chow, Kar Ven Cavan, O’Leary, Connor, Paxton-Hall, Fiona, Lambie, Duncan and O’Byrne, Kenneth (2022). Pembrolizumab-induced toxic epidermal necrolysis: case report. Oxford Medical Case Reports, 2022 (3) omac025, 112-3. doi: 10.1093/omcr/omac025
2021
Conference Publication
Identification of ctDNA using MassARRAY Technology in a Cross-Sectional Study of NSCLC Patients
Kulasinghe, A., Monkman, J., Dutta, S., O’Leary, C., Ladwa, R. and O'Byrne, K. (2021). Identification of ctDNA using MassARRAY Technology in a Cross-Sectional Study of NSCLC Patients. 2021 World Conference on Lung Cancer, Virtual, 8-14 September 2021. New York, United States: Elsevier. doi: 10.1016/j.jtho.2021.08.375
2021
Journal Article
The identification of circulating tumour DNA using MassARRAY technology in non-small-cell lung cancer (NSCLC)
Kulasinghe, Arutha, O'Leary, Connor, Monkman, James, Bharti, Vandhana, Irwin, Darryl, Dutta, Sanjay, Richard, Derek J., Hughes, Brett, Ladwa, Rahul and O'Byrne, Ken (2021). The identification of circulating tumour DNA using MassARRAY technology in non-small-cell lung cancer (NSCLC). Lung Cancer, 160, 73-77. doi: 10.1016/j.lungcan.2021.08.005
2021
Conference Publication
Characterizing the Tumour-Immune Microenvironment in EGFR Mutant NSCLC
Monkman, J., O’Leary, C., Richard, D., O'Byrne, K. and Kulasinghe, A. (2021). Characterizing the Tumour-Immune Microenvironment in EGFR Mutant NSCLC. 2021 World Conference on Lung Cancer, Virtual, 8-14 September 2021. New York, United States: Elsevier. doi: 10.1016/j.jtho.2021.08.605
2021
Journal Article
Pregnancy-associated breast cancer: evaluating maternal and foetal outcomes. A national study
Prior, Lisa, O'Dwyer, Richard, Farooq, Abdul Rehman, Greally, Megan, Ward, Cian, O'Leary, Connor, Aslam, Razia, Darwish, Waseem, Ahmed, Nada, Othman, Elly Che, Watson, Geoffrey, Kelly, Deirdre, Gleeson, Jack, Kiely, Lisa, Hassan, Anees, Walsh, Elaine M., O'Reilly, David, Jones, Alfred, Featherstone, Hannah, Lim, Marvin, Murray, Hazel, Hennessy, Bryan T., Smyth, Lillian M., Leonard, Gregory, Grogan, Liam, Breathnach, Oscar, Calvert, Paula, Horgan, Anne M., Coate, Linda ... Walshe, Janice M. (2021). Pregnancy-associated breast cancer: evaluating maternal and foetal outcomes. A national study. Breast Cancer Research and Treatment, 189 (1), 269-283. doi: 10.1007/s10549-021-06263-y
2021
Conference Publication
The role of the immune microenvironment in EGFR mutant NSCLC
Monkman, James, Kulasinghe, Arutha, O’Leary, Connor, Richard, Derek and O’Byrne, Ken (2021). The role of the immune microenvironment in EGFR mutant NSCLC. 19th Annual British Thoracic Oncology Group Conference, Online, 22-23 April 2021. Shannon, Ireland: Elsevier Ireland. doi: 10.1016/s0169-5002(21)00204-x
2021
Conference Publication
The identification of circulating tumour DNA using MassARRAY technology in non-small-cell lung cancer (NSCLC)
Kulasinghe, Arutha, Monkman, James, Dutta, Sanjay, O'Leary, Connor, Ladwa, Rahul and O'Byrne, Ken (2021). The identification of circulating tumour DNA using MassARRAY technology in non-small-cell lung cancer (NSCLC). 19th Annual British Thoracic Oncology Group Conference 2021, Virtual, 22-23 April 2021. Shannon, Ireland: Elsevier. doi: 10.1016/S0169-5002(21)00199-9
2021
Conference Publication
The identification of circulating tumour DNA using MassARRAY technology in non-small-cell lung cancer (NSCLC)
Kulasinghe, Arutha, Monkman, James, Dutta, Sanjay, O’Leary, Connor, Ladwa, Rahul and O’Byrne, Ken (2021). The identification of circulating tumour DNA using MassARRAY technology in non-small-cell lung cancer (NSCLC). 19th Annual British Thoracic Oncology Group Conference 2021, Virtual, 22-23 April 2021. Shannon, Ireland: Elsevier Ireland. doi: 10.1016/s0169-5002(21)00199-9
2021
Journal Article
Identification of proteins deregulated by platinum-based chemotherapy as novel biomarkers and therapeutic targets in non-small cell lung cancer
Ryan, Sarah-Louise, Dave, Keyur A., Beard, Sam, Gyimesi, Martina, McTaggart, Matthew, Sahin, Katherine B., Molloy, Christopher, Gandhi, Neha S., Boittier, Eric, O'Leary, Connor G., Shah, Esha T., Bolderson, Emma, Baird, Anne-Marie, Richard, Derek J., O'Byrne, Kenneth J. and Adams, Mark N. (2021). Identification of proteins deregulated by platinum-based chemotherapy as novel biomarkers and therapeutic targets in non-small cell lung cancer. Frontiers in Oncology, 11 615967. doi: 10.3389/fonc.2021.615967
2021
Conference Publication
TS01.06 High-Plex Digital Spatial Profiling of Non-Small-Cell Lung Cancer (NSCLC)
Kulasinghe, A., Monkman, J., Taheri, T., Warkiani, M., O’leary, C., Ladwa, R., Richard, D. and O'Byrne, K. (2021). TS01.06 High-Plex Digital Spatial Profiling of Non-Small-Cell Lung Cancer (NSCLC). 2020 North America Conference on Lung Cancer, Virtual, 16-17 October 2020. New York, United States: Elsevier. doi: 10.1016/j.jtho.2020.10.098
Supervision
Availability
- Dr Connor OLeary is:
- Available for supervision
Looking for a supervisor? Read our advice on how to choose a supervisor.
Media
Enquiries
For media enquiries about Dr Connor OLeary's areas of expertise, story ideas and help finding experts, contact our Media team: